Michael Wagner

5.4k total citations
96 papers, 3.4k citations indexed

About

Michael Wagner is a scholar working on Molecular Biology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Wagner has authored 96 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 27 papers in Hepatology and 25 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Wagner's work include Hepatitis C virus research (27 papers), Cardiac electrophysiology and arrhythmias (17 papers) and Liver Disease Diagnosis and Treatment (17 papers). Michael Wagner is often cited by papers focused on Hepatitis C virus research (27 papers), Cardiac electrophysiology and arrhythmias (17 papers) and Liver Disease Diagnosis and Treatment (17 papers). Michael Wagner collaborates with scholars based in Germany, United States and Netherlands. Michael Wagner's co-authors include Stefan Zeuzem, Christoph Sarrazin, Eva Herrmann, Thomas Berg, Tobias Heintges, J. Rasenack, Tilmann Volk, G Teuber, Christoph Maack and Bernd Kronenberger and has published in prestigious journals such as Journal of Clinical Investigation, Physical review. B, Condensed matter and Gastroenterology.

In The Last Decade

Michael Wagner

94 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Wagner Germany 29 1.6k 1.5k 732 475 232 96 3.4k
Takafumi Saito Japan 27 879 0.5× 869 0.6× 518 0.7× 103 0.2× 189 0.8× 163 2.6k
Takahiro Sato Japan 29 808 0.5× 808 0.5× 401 0.5× 641 1.3× 178 0.8× 192 3.2k
Takahisa Kawaguchi Japan 28 350 0.2× 796 0.5× 1000 1.4× 328 0.7× 288 1.2× 132 3.7k
Martin Braddock United Kingdom 37 358 0.2× 715 0.5× 1.4k 1.9× 207 0.4× 201 0.9× 131 3.7k
Amar P. Dhillon United Kingdom 37 1.4k 0.8× 1.5k 1.0× 1.1k 1.5× 136 0.3× 258 1.1× 80 5.1k
Hajime Nakamura Japan 33 818 0.5× 638 0.4× 802 1.1× 190 0.4× 157 0.7× 189 3.9k
Akira Takada Japan 28 1.2k 0.8× 1.4k 0.9× 508 0.7× 126 0.3× 865 3.7× 95 2.8k
Carsten H. Meyer Germany 44 787 0.5× 760 0.5× 998 1.4× 507 1.1× 93 0.4× 314 6.8k
Lisa Richards United States 30 1.3k 0.8× 2.7k 1.8× 705 1.0× 215 0.5× 259 1.1× 85 3.8k
Koji Ogawa Japan 27 449 0.3× 449 0.3× 923 1.3× 211 0.4× 278 1.2× 222 3.1k

Countries citing papers authored by Michael Wagner

Since Specialization
Citations

This map shows the geographic impact of Michael Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wagner more than expected).

Fields of papers citing papers by Michael Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wagner. The network helps show where Michael Wagner may publish in the future.

Co-authorship network of co-authors of Michael Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wagner. A scholar is included among the top collaborators of Michael Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wagner. Michael Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaaf, Jannik, et al.. (2024). Initial User-Centred Design of an AI-Based Clinical Decision Support System for Primary Care. Studies in health technology and informatics. 310. 1051–1055. 6 indexed citations
2.
Schaaf, Jannik, et al.. (2024). Exploring patient-centered design solutions of a telehealth app for HIV − A qualitative study. International Journal of Medical Informatics. 189. 105524–105524. 3 indexed citations
3.
Wagner, Michael, et al.. (2024). Translation of Ontological Concepts from English into German Using Commercial Translation Software and Expert Evaluation. Studies in health technology and informatics. 310. 89–93. 3 indexed citations
4.
Schaaf, Jannik, et al.. (2023). Interviews with HIV Experts for Development of a Mobile Health Application in HIV Care—A Qualitative Study. Healthcare. 11(15). 2180–2180. 4 indexed citations
5.
Schaaf, Jannik, et al.. (2023). Diagnosis Support for Rare Diseases Using Phenotypic Profiles. Studies in health technology and informatics. 302. 607–608.
6.
Kirstein, Bettina, Julia Mayer, Stefan Ulbrich, et al.. (2022). Effect of concomitant Renal DeNervation and cardiac ablation on Atrial Fibrillation recurrence – RDN+AF study. Journal of Cardiovascular Electrophysiology. 34(1). 44–53. 6 indexed citations
7.
8.
Kirstein, Bettina, Thomas Gaspar, Judith Piorkowski, et al.. (2020). Left atrial fibrosis predicts left ventricular ejection fraction response after atrial fibrillation ablation in heart failure patients: the Fibrosis-HF Study. EP Europace. 22(12). 1812–1821. 18 indexed citations
9.
Schaaf, Jannik, Martin Sedlmayr, Hans‐Ulrich Prokosch, et al.. (2020). The Status Quo of Rare Diseases Centres for the Development of a Clinical Decision Support System – A Cross-Sectional Study. Studies in health technology and informatics. 271. 176–183. 4 indexed citations
10.
Schaaf, Jannik, Martin Boeker, Thomas Ganslandt, et al.. (2019). Finding the Needle in the Hay Stack: An Open Architecture to Support Diagnosis of Undiagnosed Patients. Studies in health technology and informatics. 264. 1580–1581. 7 indexed citations
11.
Schroll, Stephan, et al.. (2012). Improvement of exercise capacity in monocrotaline-induced pulmonary hypertension by the phosphodiesterase-5 inhibitor Vardenafil. Respiratory Physiology & Neurobiology. 186(1). 61–64. 6 indexed citations
12.
Welker, Martin‐Walter, Michael Wagner, Vincent Zimmer, et al.. (2010). Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C. Digestive and Liver Disease. 42(10). 735–740. 2 indexed citations
13.
Lange, Christian M., Jörg Bojunga, Elizabeth Ramos‐Lopez, et al.. (2010). Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. Journal of Hepatology. 54(5). 887–893. 199 indexed citations
14.
Heitzmann, Dirk, Michael Wagner, Christina Sterner, et al.. (2007). KCNE Beta Subunits Determine pH Sensitivity of KCNQ1 Potassium Channels. Cellular Physiology and Biochemistry. 19(1-4). 21–32. 41 indexed citations
15.
Wagner, Michael, et al.. (2007). Modulation of the transient outward K+ current by inhibition of endothelin-A receptors in normal and hypertrophied rat hearts. Pflügers Archiv - European Journal of Physiology. 454(4). 595–604. 6 indexed citations
16.
Lagging, Martin, Ana I. Romero, Johan Westin, et al.. (2006). IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology. 44(6). 1617–1625. 179 indexed citations
17.
Berg, Thomas, Michael Wagner, Samer Nasser, et al.. (2006). Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin. Gastroenterology. 130(4). 1086–1097. 368 indexed citations
18.
Welker, Martin, Wolf Peter Hofmann, Christoph Welsch, et al.. (2006). Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon‐alpha‐based therapy in HCV‐1b‐infected patients. Journal of Viral Hepatitis. 14(5). 338–349. 13 indexed citations
19.
Wagner, Michael, M Huber, Thomas Berg, et al.. (2005). Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C. Gastroenterology. 129(2). 522–527. 319 indexed citations
20.
Kronenberger, Bernd, Christoph Sarrazin, Wolf Peter Hofmann, et al.. (2004). Mutations in the putative HCV‐E2 CD81 binding regions and correlation with cell surface CD81 expression. Journal of Viral Hepatitis. 11(4). 310–318. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takafumi Saito Breakdown of academic impact, for papers by Takahiro Sato Breakdown of academic impact, for papers by Takahisa Kawaguchi Breakdown of academic impact, for papers by Martin Braddock Breakdown of academic impact, for papers by Amar P. Dhillon Breakdown of academic impact, for papers by Hajime Nakamura Breakdown of academic impact, for papers by Akira Takada Breakdown of academic impact, for papers by Carsten H. Meyer Breakdown of academic impact, for papers by Lisa Richards Breakdown of academic impact, for papers by Koji Ogawa
Rankless by CCL
2026